4//SEC Filing
DENKHAUS DONALD A 4
Accession 0001161697-24-000062
CIK 0001369568other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 5:00 PM ET
Size
7.2 KB
Accession
0001161697-24-000062
Insider Transaction Report
Form 4
DENKHAUS DONALD A
Director
Transactions
- Exercise/Conversion
Common Stock, par value $0.001 per share
2024-02-05$4.01/sh+40,000$160,400→ 434,333 total - Exercise/Conversion
Options to purchase common stock
2024-02-05−40,000→ 192,931 totalExercise: $4.01Exp: 2025-01-02→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]Derivative securities vested in three equal tranches on January 2, 2019, 2020 and 2021.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0001278439
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 5:00 PM ET
- Size
- 7.2 KB